AETHLON MEDICAL, INC. Share-based Payment Arrangement, Expense
AETHLON MEDICAL, INC. (AEMD) reported Share-based Payment Arrangement, Expense of $50.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- AETHLON MEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $50.00K, a 30.98% decline year-over-year.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $72.44K, a 19.48% decline year-over-year.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $72.44K.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $72.44K.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense for fiscal 2014 was $607.95K, a 20.56% decline from fiscal 2013.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense for fiscal 2013 was $765.27K, a 0.83% increase from fiscal 2012.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense for fiscal 2012 was $758.96K, a 57.24% decline from fiscal 2011.
- AETHLON MEDICAL, INC. share-based payment arrangement, expense for fiscal 2011 was $1.77M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $72.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $144.88K derived: sum of 2 quarters · filed 2026-02-12 | $217.33K 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $72.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | $144.88K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $72.44K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $89.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $342.79K 10-Q · filed 2026-02-12 | ||
| 2024-09-30 | $252.82K 10-Q · filed 2025-11-12 | |||
| 2023-09-30 | $507.30K 10-Q · filed 2024-11-13 | |||
| 2014-12-31 | $77.90K 10-Q · filed 2015-02-10 | $167.69K derived: sum of 2 quarters · filed 2015-02-10 | $338.58K 10-Q · filed 2015-02-10 | $723.17K derived: sum of 4 quarters · filed 2015-02-10 |
| 2014-09-30 | $89.79K 10-Q · filed 2014-11-10 | $260.68K 10-Q · filed 2014-11-10 | $645.27K derived: sum of 3 quarters · filed 2014-11-10 | $678.02K derived: sum of 4 quarters · filed 2015-02-10 |
| 2014-06-30 | $170.89K 10-Q · filed 2014-08-14 | $555.48K derived: sum of 2 quarters · filed 2014-08-14 | $588.23K derived: sum of 3 quarters · filed 2015-02-10 | $663.04K derived: sum of 4 quarters · filed 2015-02-10 |
| 2014-03-31 | $384.60K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $417.35K derived: sum of 2 quarters · filed 2015-02-10 | $492.16K derived: sum of 3 quarters · filed 2015-02-10 | $607.95K 10-K · filed 2014-07-15 |
| 2013-12-31 | $32.75K 10-Q · filed 2015-02-10 | $107.56K derived: sum of 2 quarters · filed 2015-02-10 | $223.35K 10-Q · filed 2015-02-10 | $418.08K derived: sum of 4 quarters · filed 2015-02-10 |
| 2013-09-30 | $74.81K 10-Q · filed 2014-11-10 | $190.60K 10-Q · filed 2014-11-10 | $385.33K derived: sum of 3 quarters · filed 2014-11-10 | $560.38K derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | $115.79K 10-Q · filed 2014-08-14 | $310.52K derived: sum of 2 quarters · filed 2014-08-14 | $485.57K derived: sum of 3 quarters · filed 2014-08-14 | $711.76K derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $194.73K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $369.78K derived: sum of 2 quarters · filed 2014-07-15 | $595.97K derived: sum of 3 quarters · filed 2014-07-15 | $765.27K 10-K · filed 2014-07-15 |
| 2012-12-31 | $175.04K 10-Q · filed 2014-02-11 | $401.24K derived: sum of 2 quarters · filed 2014-02-11 | $570.54K 10-Q · filed 2014-02-11 | $720.00K derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-09-30 | $226.20K 10-Q · filed 2013-11-14 | $395.50K 10-Q · filed 2013-11-14 | $544.96K derived: sum of 3 quarters · filed 2013-11-14 | $706.39K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $169.30K 10-Q · filed 2013-08-13 | $318.76K derived: sum of 2 quarters · filed 2013-08-13 | $480.20K derived: sum of 3 quarters · filed 2013-08-13 | $704.23K derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | $149.46K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-15 | $310.90K derived: sum of 2 quarters · filed 2013-07-15 | $534.93K derived: sum of 3 quarters · filed 2013-07-15 | $758.96K 10-K · filed 2013-07-15 |
| 2011-12-31 | $161.44K 10-Q · filed 2013-02-12 | $385.47K derived: sum of 2 quarters · filed 2013-02-12 | $609.50K 10-Q · filed 2013-02-12 | |
| 2011-09-30 | $224.03K 10-Q · filed 2012-11-13 | $448.06K 10-Q · filed 2012-11-13 | ||
| 2011-06-30 | $224.03K 10-Q/A · filed 2012-08-28 | |||
| 2011-03-31 | $1.77M 10-K · filed 2012-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |